Epitope spreading toward wild-type melanocyte-lineage antigens rescues suboptimal immune checkpoint blockade responses is a research paper published in Science Translational Medicine (2021). On theSindex it has a DataRank of 0.691. It has been cited 99 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.691
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institutes of Health
Grant: P01 AI056299
National Cancer Institute
Grant: P50CA101942
National Cancer Institute
Grant: P50CA206963
Swiss National Science Foundation
Grant: 178022
Defining the molecular basis of CD4 Treg conversion for effective anti-tumor immunity
NIGMS NIH HHS
Grant: T32 GM007753
NIEHS NIH HHS
Grant: F30 ES025626
NCI NIH HHS
Grant: P01 CA163222
NCI NIH HHS
Grant: P30 CA006516
NCI NIH HHS
Grant: R01 CA222871
NIAMS NIH HHS
Grant: R01 AR043369
NIAMS NIH HHS
Grant: R01 AR072304
NCI NIH HHS
Grant: R01 CA155010
NCI NIH HHS
Grant: T32 CA207021
National Institutes of Health
Grant: 5R01AR043369-28
MITF from control of pigmentation to melanoma risk
Wellcome Trust
Grant: unidentified
unidentified
National Institutes of Health
Grant: 5P01AI056299-12
T Cell Costimulatory Pathways: Functions and Interactions
National Institutes of Health
Grant: 1R01CA222871-01
A druggable dependency in low-MITF/high-AXL melanoma: preclinical efficacy and mechanism of action in a key treatment-resistant subclass.
National Institutes of Health
Grant: 2P50CA101942-11A1
DF/HCC Kidney Cancer SPORE
National Institutes of Health
Grant: 1F30ES025626-01
The roles of UV, neoantigens, and epitope spreading in vitiligo and melanoma
National Institutes of Health
Grant: 3T32GM007753-41S1
Medical Scientist Training Program
National Institutes of Health
Grant: 5R01AR072304-04
Preclinical models and therapeutic strategies for treatment of giant congenital melanocytic nevi
National Institutes of Health
Grant: 3P30CA006516-41S6
CANCER CENTER SUPPORT GRANT
National Institutes of Health
Grant: 5P01CA163222-08
Targetable epigenetic and transcriptional mechanisms in melanoma that shape the microenvironment
National Institutes of Health
Grant: 7P50CA206963-03
SPORE in Myeloid Malignancies
National Science Foundation
Cancer Research Institute
Cancer Research UK
Dr. Mildred Scheel Stiftung für Krebsforschung
Dr. Miriam and Sheldon G. Adelson Medical Research Foundation
Leukemia and Lymphoma Society
Swiss National Science Foundation
FWCI
5.75
Citation Percentile
1.0%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals
Additional file 1 of Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs
Additional file 1 of Inhibition of post-surgery tumour recurrence via a sprayable chemo-immunotherapy gel releasing PD-L1 antibody and platelet-derived small EVs